Application of Virtual Reality Technology to Treatment of Social Anxiety
Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER, HOUSTON · Feb 19, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how virtual reality (VR) technology can help adults with autism spectrum disorder (ASD) and social anxiety disorder (SAD) feel less anxious in social situations. The study will compare two different treatments: one using VR to practice social skills and face social fears, and another using traditional methods like talking therapy and mindfulness. Researchers want to find out which method is more effective, who benefits the most from the VR treatment, and how well patients like and can use this new approach.
To participate in this trial, you need to be diagnosed with autism and social anxiety, be able to speak and read in English or Spanish, and have average or above-average intellectual ability. You should also be comfortable using a computer. However, individuals with severe mental illnesses or those who cannot use technology will not be eligible. If you join, you can expect to take part in sessions that use VR to help manage social anxiety, and your experiences will help shape future treatments for others.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Autism Spectrum Disorder (ASD) (diagnosed by a qualified professional)
- • verbal and literate in English or Spanish
- • average or greater intellectual ability, based on history and interview
- • able to operate a computer (Windows or Mac).
- Exclusion Criteria:
- • current or historical severe mental illness such as schizophrenia, bipolar disorder, or severe depression
- • intellectual disability or a learning disability that would interfere with participating (e.g., unable to read)
- • unable use the technology or do not have access to the technology
- • unable to read
About The University Of Texas Health Science Center, Houston
The University of Texas Health Science Center at Houston (UTHealth) is a leading academic institution dedicated to advancing health through education, research, and clinical practice. As a prominent sponsor of clinical trials, UTHealth leverages its extensive resources and expertise in biomedical research to facilitate innovative studies aimed at improving patient outcomes. The institution is committed to fostering a collaborative environment that promotes scientific discovery and the translation of research findings into effective healthcare solutions, all while adhering to the highest ethical standards and regulatory guidelines. With a multidisciplinary approach, UTHealth plays a critical role in addressing complex health challenges and enhancing the quality of life in diverse communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Katherine Loveland, PhD
Principal Investigator
The University of Texas Health Science Center at Houstom
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported